ARCHIVES

Final Issue of 1980

This article is from The Cancer Letter archive.

Vol. 06 No. 50 | December 19, 1980

Download PDF Visit The Full Archive

Related Articles

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

Drug Reimbursement: Senate Bill Worse For Oncologists

July 11, 1997

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984